June 2020
Volume 61, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2020
A Facilitated Hammerhead Ribozyme Rhodopsin Therapeutic with Catalytic Efficiency on Par with Ribonuclease A at Cellular Free Mg2+ Levels
Author Affiliations & Notes
  • Jack M Sullivan
    Ophthalmology, University at Buffalo- SUNY, Buffalo, New York, United States
    Medical Research, VA Western NY Healthcare System, Buffalo, New York, United States
  • Jason Myers
    Ophthalmology, University at Buffalo- SUNY, Buffalo, New York, United States
    Medical Research, VA Western NY Healthcare System, Buffalo, New York, United States
  • Footnotes
    Commercial Relationships   Jack Sullivan, Research Foundation of SUNY; Veterans Administration (P); Jason Myers, Research Foundation of SUNY; Veterans Admininstration (P)
  • Footnotes
    Support  NIH/NEI R01 EY013433; VA Merit I01 BX000669
Investigative Ophthalmology & Visual Science June 2020, Vol.61, 4481. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jack M Sullivan, Jason Myers; A Facilitated Hammerhead Ribozyme Rhodopsin Therapeutic with Catalytic Efficiency on Par with Ribonuclease A at Cellular Free Mg2+ Levels. Invest. Ophthalmol. Vis. Sci. 2020;61(7):4481.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To rigorously characterize the catalytic efficiency of a novel Facilitated hammerhead ribozyme (F-hhRz) and evaluate its sensitivity to free Mg2+ levels. The F-hhRz (F-hhRz-266-A7U-12bp) is a lead therapeutic ribozyme candidate that attacks human rhodopsin mRNA at CUC↓266, a position in the full length mRNA that is accessible to therapeutic RNA annealing and cleavage. F-hhRzs are catalytic RNAs with orders of magnitude improvement in catalysis compared to historical agents.

Methods : Substrate RHO-266 RNA is a 15 nt long substrate with 5’ FAM and 3’ BHQ1 (IDT); cleavage at centered CUC↓ 266 results in liberation of quenched fluorescence which is quantified optically. Ribozyme RNAs with natural nucleotides are also generated synthetically (IDT). Reactions are initiated by mixing F-hhRz with substrate RNA in buffer (10 mM Tris-HCl, pH 7.5) at specified free Mg2+ and optically measured at 37°C in a qRT/PCR machine (Cepheid). Data are analyzed in Origin 8 (Microcal).

Results : At 1 μM Substrate the cleavage rate fit with respect to F-hhRz concentration (0-500 nM) shows an expected linear relationship with a slope of 2.18 E9 min-1M-1 (R2 = 0.991). At 50 nM F-hhRz and 0.5 mM Mg2+ the relationship of observed rate (kobs) with Substrate concentration (0-5000 nM) was well fit by the nonlinear Michaelis-Menten equation (R2 = 0.993); fitting of the data to the Eadie-Hofstee linear transformation of the equation (R2 = 0.9517) identified Vmax = 164 ± 0.25 min-1 and Km = 629.9 ± 2.32 nM, leading to an enzyme efficiency (Vmax/Km) = 2.60 E8 min-1M-1. At 100 nM F-hhRz and 1 μM Substrate ([S]:[E] = 10:1) the Mg2+ sensitivity (0-20 mM) of kobs is best fit by an independent two-site Boltzmann titration model (R2 = 0.995) with approximately equal weights (0.491 ± 0.113) with Km1 = 0.723 ± 0.058 mM and Km2 = 5.00 ± 1.12 mM and slope factors k1 = 0.304± 0.054 and k2= 1.648± 0.922; a cooperative two-site Hill model did not fit the data well.

Conclusions : The reported enzyme efficiency of proteinaceous RNaseA enzyme is 1.38 E8 min-1M-1. The F-hhRz RNA has a catalytic efficiency that rivals a highly efficient protein enzyme that is thought to use the same reaction mechanism in RNA cleavage. F-hhRzs have substantial potential as RNA therapeutics because they can reduce target mRNA levels at lower levels of their own expression, and they function at cellular levels of free Mg2+.

This is a 2020 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×